Showing results (641-650 of 843) with videos related to

Sort By:
Pageof 85
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 31, 2022
Nebulized mRNA-Encoded Antibodies Protect Hamsters from SARS-CoV-2 InfectionDaryll Vanover, Chiara Zurla, Hannah E Peck, et al.
Journal of Virology|September 2, 2011
Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodiesZhongyu Zhu, Haiyan Rebekah Qin, Weizao Chen, et al.
Clinical and Vaccine Immunology : CVI|August 1, 2014
Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaquesJaimie D Sixsmith, Michael W Panas, Sunhee Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 25, 2016
Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized MiceKevin Wiehe, Nathan I Nicely, Bradley Lockwood, et al.
Plos One|March 12, 2014
IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteriaKwan-Ki Hwang, Ashley M Trama, Daniel M Kozink, et al.
Molecular Cell|April 21, 2022
Structural diversity of the SARS-CoV-2 Omicron spikeSophie M-C Gobeil, Rory Henderson, Victoria Stalls, et al.
The Journal of Clinical Investigation|April 3, 2025
Safety and implementation of phase I randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newbornsAvy Violari, Kennedy Otwombe, William Hahn, et al.
Plos One|September 3, 2010
Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencingWill Fischer, Vitaly V Ganusov, Elena E Giorgi, et al.
JAMA|October 24, 2013
Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trialLisa R Metsch, Daniel J Feaster, Lauren Gooden, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2013
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgGGeorgia D Tomaras, Guido Ferrari, Xiaoying Shen, et al.
Pageof 85